The Urease Inhibitors Therapy in Infected Renal Stones: In vitro and in vivo experiences with a new drug: The propionohydroxamic acid (PHA)

Griffith D. P. , Gibson J. R. , Clinton C.W. , Musher D. M. : Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi. J. Urol., 119; 9–15 (1978).

Musher D. M. , Saenz C. , Griffith D. P. : Interaction between acetohydroxamic acid and 12 antibiotics against 14 Gram-negative pathogenic bacteria. Antimicrob. Agents Chemother., 5; 106–110 (1974).

Griffith D. P. , Musher D. M. : Pathogenesis of infection stones. Proceedings of the International Colloquium on Urinary Stones. Edited by Finlayson B. and Thomas W. C. (in press).

Griffith D. P. , Musher D. M. , Itin C. : Urease: the primary cause of infection- induced urinary stones. Invest. Urol., 13; 346 (1976).

Griffith D. P. , Musher D. M. : Acetohydroxamic acid: potential use in urinary infection caused by urea-splitting bacteria. Urology, 5; 299 (1975).

Chaube S. , Murphy M. L. : The effects of hydroxyurea and related compounds on the rat fetus. Cancer Res., 26; 1448 (1966).

Griffith D. P. , Musher D. M. , Campbell J. W. : Inhibitor of bacterial urease. Invest. Urol., 11; 234 (1973).

Griffith D. P. , Musher D. M. : Prevention of infected urinary stones by urease inhibition. Invest. Urol., 11; 228 (1973).

Fishbein W. N. , Daly J. , Steeter C. L. : Preparation and some properties of stable and carbon-14 and tritium-labeled short chain aliphatic hydroxamic acids. Anal. Biochem., 28; 13 (1969).

Kobashi K. , Takebe S. , Terashima N. , Hose J. : Inhibition of urease activity by the hidroxamic acid derivatives of amino acids. J. Biochem., 77; 837 (1975).

Kobashi K. , Kumaki K. , Hose J. : Effect of acyl residues of hydroxamic acids on urease inhibition. Biochem. Biophys. Acta, 227; 429 (1971).

Fishbein W. N. , Daly J. E. : Urease inhibitors for hepatic coma. II. Comparative efficacy of four lower hydroxamate homologs in vitro and in vivo. Proc. Soc. Exp. Biol. Med., 134; 1083 (1970).

Fishbein W. N. : Urease inhibition for hepatic coma: inhibition of 14-C urea hydrolysis in mice by alkyl hydroxamates. Biochem. Med., 1; 111 (1970).

Fishbein W. N. , Carbone P. P. , Hochstein H. D. : Acetohydroxamate: bacterial urease inhibitor with therapeutic potential in hyperammonaemic states. Nature, 208; 46 (1965).

Musher D. M. , Griffith D. P. , Rosen R. D. : The role of urease in pyelonephritis resulting from urinary infection with Proteus. J. Infect. Dis., 131; 177 (1975).

Musher D. M. , Griffith D. P. , Tyler M. , Woelfel A. : Potentiation of the antibacterial effect of methepamine by acetohydroxamic acid. Antimicrob. Agents Chemother., 5; 101 (1974).

Fishbein W. N. , Streeter C. I. : Physiologic disposition of short chain aliphatic hydroxamates in the mouse. I. The one-through-four carbon hydroxamates; excretion and conversion to amides. J. Pharmacol. Exp. Ther., 174; 239–246 (1970).

Gale G. R. : Urease activity and antibiotic sensivity of bacteria. J. Bacteriol., 91; 499–506 (1966).

Summerskill W. H. J F. , Thorsell J. H. , Aldrete J. S. : Effects of urease inhibition in hyperammonemia: clinical and experimental studies with acetohydroxamic acid. Gastroenterology, 54; 20–27 (1968).

Wolpert E. A. F , Hofmann F. , Summerskill W. H. J. : Syntesis and metabolism of labeled acetohydroxamic acid, a urease inhibitor. Proc. Soc. Exp. Biol. Med., 136; 592–596 (1971).

Wolpert E. , Phillips S. F. , Summerskill H. J. W. : Ammonia production in the human colon: effects of cleansing neomicin and acetohydroxamic add. N. Engl. J. Med., 283; 159–164 (1970).

Martelli A. , Buli P. , Cortecchia V. : Acetohydroxamic add therapy in infected renal stones. Urology, 17; 320–322 (1981).

Martelli A. , Buli P. , Cortecchia V. : Urease inhibitor therapy in infected renal stones. Eur. Urol., 7; 291–293 (1981).

Kreybig Th. (von) , Preussmann R. , Schmidt W. : Chemische Konstitution und teratogene Wirkung bei der Ratte. Arzneim. Forsch., 18; 645–657 (1968).